- Projects & figures
- News & Events
- Managing your project
- About ERC
An EU-funded project is exploring what keeps people committed to a task even when they get bored, distracted or are tempted to stop. The findings could foster productivity-boosting strategies, improve robot-human interactions and even help treat borderline personality disorder.
On 30 November and 1st December, the G20 2018 Summit will take place in Buenos Aires, Argentina. The leaders and Ministers of finances of the World's major economies, including the European Union, will address the pressing concerns and challenges related to the global economy and finances. In this high decision-making forum, Prof. Irma Mosquera Valderrama has managed to make a place for her independent expertise, raising the voices of developing countries.
At the forefront of medicine, gene therapy is based on the insertion of genes into an individual's cells and tissues to treat a disease. Scientists are currently testing several approaches to this experimental technique. One of them, Prof. Seppo Ylä-Herttuala, intends to develop a novel method to treat myocardial ischemia by activating endogenous genes to propel angiogenesis. If successful, he will open a new era in gene therapy.
Based on University of Turku's press release
For more than 3000 years, men have captured wild Asian elephants to use them for work or entertainment. In a new study published today in Nature Communications, ERC grantee Virpi Lummaa shows the harmful effects of these ongoing practices on wild-caught animals. The findings are based on detailed records from the past 100 years over a population of 5000 timber elephants from Myanmar.
Once limited to modelling physical problems in engineering, today Partial Differential Equations (PDEs) are used by a diverse array of fields, from natural resources to meteorology, aeronautics, oil and gas and biomedicine – to name only a few. But key mathematical issues remain unsolved, particularly when addressing their control, a must in technological transfer. The ERC-funded DYCON project aims to find answers.
CRISPR is a widely used molecular biology tool exploiting an immune process discovered in bacteria. Dr David Bikard studies CRISPR in bacterial cells, in conjunction with different DNA repair systems, to create even newer tools. He hopes to gain insight into bacterial genetics, and develop increasingly effective medical treatments.
Epithelial tissues cover all body surfaces and line most of our organs, internal cavities and passageways, including the digestive tract. Prof. Elena Martínez is engineering intestinal epithelial tissues that mimic the physiological characteristics of human intestinal tissue with the aim of advancing the in vitro modelling of diseases, the preclinical screening for drug efficacy and toxicity, and the understanding of organ development.
Toxicology and pharmacology assays are currently carried out in cell lines or experimental animals. Scientists of the TOXANOID project developed mini organs in a dish, which outperform existing in vitro systems.
Emulsions play a key role both in natural and industrial processes, as they allow the combination of two liquids that do not normally mix and make the blend stable. Yet, when materials solidify or freeze, the complex interactions that take place and affect the final microstructure of the solidified components, are still poorly understood. ERC grantee Sylvain Deville and his team at CNRS have showed that it is possible to use an optical imaging technique to study the freezing of emulsions while the process takes place, a novel method presented in the prestigious journal Science.
ERC grantee Erik van Sebille is developing advanced modelling tools to help assess the full extent of the problem of plastic pollution in our oceans and how it is affecting the marine environment. The tools will help policymakers design targeted measures to address a big and growing issue.